Zimmer Biomet to Present at Goldman Sachs CEOs Unscripted Conference and 41st Annual J.P. Morgan Healthcare Conference PressReach · Dec 14, 2022
AbbVie Named to Dow Jones Sustainability World Index for 10th Straight Year PressReach · Dec 13, 2022
One in Two Patients Tested Misuse Prescription Drugs, Finds 10th Annual Quest Diagnostics Health Trends® Report PressReach · Dec 13, 2022
Linvoseltamab (BCMAxCD3) Initial Pivotal Phase 2 Data Show Clinically Meaningful Responses in Patients with Heavily Pre-treated Multiple Myeloma PressReach · Dec 13, 2022
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Spectrum To Contact Him Directly To Discuss Their Options PressReach · Dec 13, 2022
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Welltower To Contact Him Directly To Discuss Their Options PressReach · Dec 13, 2022
West Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference PressReach · Dec 13, 2022
Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets PressReach · Dec 13, 2022
AbbVie Presents Data at the 64th American Society of Hematology (ASH) Annual Meeting Evaluating Epcoritamab (DuoBody®-CD3xCD20) Across B-Cell Lymphomas PressReach · Dec 12, 2022
Boston Scientific Announces Strategic Investment to Acquire Majority Stake of Acotec Scientific Holdings Limited PressReach · Dec 12, 2022
Tonix Pharmaceuticals Announces Exclusive License of Potential Therapeutic or Preventative Humanized anti-SARS-CoV-2 Monoclonal Antibodies from Curia Global, Inc. PressReach · Dec 12, 2022